Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant vs Anastrozole in ER+ Advanced Breast Cancer
NCT00327769Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fulvestrant in breast cancer, sponsored by AstraZeneca. Started Nov 2005; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00327769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327769.